The Journal of Allergy and Clinical Immunology
Volume 122, Issue 4 , Pages 829-831 , October 2008

Administration of oral vitamin D induces cathelicidin production in atopic individuals

References 

  1. Schultz-Larsen FV, Hanifin JM. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am. 2002;22:1–24
  2. Boguniewicz M, Leung DY. Atopic dermatitis. J Allergy Clin Immunol. 2006;117:S475–S480
  3. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151–1160
  4. Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol. 2008;122:261–266
  5. Liu P, Stenger S, Li H, Wenzel L, Tan B, Krutzik S, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–1773
  6. Schauber J, Dorschner R, Coda A, Büchau A, Liu P, Kiken D, et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest. 2007;117:803–811
  7. Vieth R, Chan P, MacFarlane G. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001;73:288–294
  8. Holick M. Vitamin D deficiency. N Engl J Med. 2007;357:266–281

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(08)01551-0

doi: 10.1016/j.jaci.2008.08.020

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 4 , Pages 829-831 , October 2008

Article Tools

* Image Usage & Resolution